Table IV.
Frequency at which physicians found pharmacogenomics clinical decision support (PGx-CDS) content presented during the study useful, very useful or extremely useful among fifty-seven encounters with the third through fifth clinical case scenarios.
Content type for each clinical case scenario | Genetic test results (%) | Gene specific resources (%) | Alert message (%) | Alert message evidence (%) |
---|---|---|---|---|
Cardiology medications | ||||
Warfarin (n=7) | 71% | 57% | 86% | 29% |
Clopidogrel (n=7) | 86% | 71% | 86% | 86% |
Propafenone (n=7) | 71% | 86% | 71% | 57% |
Oncology medications | ||||
Irinotecan (n=11) | 82% | 82% | 82% | 64% |
Capecitabine (n=13) | 85% | 77% | 85% | 62% |
Mercaptopurine/Thioguanine (n=12) | 83% | 67% | 83% | 42% |
Total (n=57) | 81% | 74% | 82% | 56% |